Canton Strategic Holdings, Inc.

CNTN

Healthcare Biotechnology

EPS
+85.9%
Free cash flow
−600.4%

Quarter to June 2026, against a year earlier

2.06 0.13 +6.74%
Market cap
$164.1M
P/E
n/m
Fwd P/E
—
Dividend yield
—
F-score
n/a
ROIC
−8.11%
Net debt / EBITDA
0.8×
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

— — — 0.00
P/S ratio
— — — 0.00
P/FCF ratio
— — — 0.00
P/Operating CF
— — — (273.22)
P/B ratio
— — — 1.34
EV/Sales
— — — 0.00
EV/EBITDA
— — — 0.00
EV/FCF
— — — (25.94)
Current Ratio
4.98 5.29 37.75 15.70
Net Debt/EBITDA
3.62 0.86 1.13 30.98
Debt/Equity
0.01 0.00 0.00 0.00
Earnings Yield
— — — (32.36%)
Free Cash Flow Yield
— — — (3.63%)
Free Cash Flow per Share
(0.30) (2.75) (0.30) (0.04)
Book value per Share
0.99 12.42 2.26 2.10
Free Cash Flow
(1.86) (88.01) (62.46) (8.00)
EV/EBIT
— — — 0.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026